Gastroentelogical surgery
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Intended for patients who meet all of the following criteria: 1. Patients who are over 20 years old when obtaining consent (regardless of gender) 2. Patients undergoing gastroentelogical surgery (such as surgery for esophagus, stomach, small intestine, large intestine, liver, biliary tract, or pancreas) meeting wound class 2, 3, 4) . 3. Patients who have received sufficient explanation for participation in this study, and who have provided written consent.
Exclusion criteria
Exclusion criteria: Patients who violate any of the following will not be included in this study: 1) Patients who have allergy for popidone iodine. 2) follow-up failure due to pass away or other reasons 3) Patients who hav active infection excluding viral hepatitis 4) Patients who are in pregnancy or may be pregnant. 5) Patients lactating. 6) Patients with sever thyroid dysfunction. 7) Any patients who judged to be inappropriate by the study investigators.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Postoperative 30-day surgical site infection (SSI) rate | — |
Secondary
| Measure | Time frame |
|---|---|
| Postoperative 30-day superficial incisional SSI rate,deep incisional SSI rate, organ/space SSI rate. Postoperative 30- day SSI rate between urgent and elective surgery, among wound classes, between laparascopic or thoracoscopic and open surgery. Postoperative 30-day rate of positive bacterial wound culture, and their strains, and toxicity and allergies events (erythema, symptoms of allergy) rate. | — |
Contacts
Hamamatsu University School of Medicine